Federal recipient
Ariad Pharmaceuticals, Inc.
$1.6 Million committed in FY2018–FY2022
- Parent company
- Takeda Pharmaceutical Company Limited
- District
- MA-07
- Location
- 40 Landsdowne ST, Cambridge, MA, 02139
- UEI
- EVMMLCKBZS47
- DUNS
- 786227231
- Also known as
- Ariad Pharmaceuticals Inc.
How the money flows
Committed dollars by how federal money reaches Ariad Pharmaceuticals, Inc..
Contracts
$1.6M
100%
Top agencies
The agencies that pay Ariad Pharmaceuticals, Inc., by dollars committed.
What they sell
Top products and services Ariad Pharmaceuticals, Inc. sells the government under contract, by dollars committed.
Drugs and Biologicals
$2.0M
Chemicals
$79,221
Medical and Surgical Instruments, Equipment, and Supplies
$11,502
Awards
The largest individual awards to Ariad Pharmaceuticals, Inc..
Competition
How many of Ariad Pharmaceuticals, Inc.'s priced contract actions drew exactly one offer — a competition on paper with a single bidder. A high share doesn't prove anything improper; it's a flag worth a second look.
Single offer
58
91%
Multiple offers
6
9%
Committed by fiscal year
Dollars committed to Ariad Pharmaceuticals, Inc., per fiscal year (FY2018–FY2022).
How to read these numbers
- Committed to this recipient
The dollars agencies committed to them — signed contracts and awarded grants — counted in the year each action happened.
- Lifetime vs. a single year
The profile sections cover the recipient's full history on record; the headline total and the flow bar reflect the fiscal year picked at the top.
- “Active in FY X”
A fiscal-year award list shows every award with at least one action that year, at its full lifetime value — a different lens from the by-year chart, which splits each award across the years it was committed.
- Names come raw
Recipient names appear exactly as filed, and the government doesn't standardize them, so one organization can show up under a few spelling variants — worth checking near-duplicates before sizing one up.
- The colored bars
Every bar on this page splits by how the money moves:
Direct payments
